These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

776 related items for PubMed ID: 25826593

  • 1. Inhaled antibiotics in Cystic Fibrosis (CF) and non-CF bronchiectasis.
    Tay GT, Reid DW, Bell SC.
    Semin Respir Crit Care Med; 2015 Apr; 36(2):267-86. PubMed ID: 25826593
    [Abstract] [Full Text] [Related]

  • 2. Aerosolized Antibiotics.
    Restrepo MI, Keyt H, Reyes LF.
    Respir Care; 2015 Jun; 60(6):762-1; discussion 771-3. PubMed ID: 26070573
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Aerosolized antibiotics for non-cystic fibrosis bronchiectasis.
    Rubin BK, Williams RW.
    Respiration; 2014 Jun; 88(3):177-84. PubMed ID: 25171580
    [Abstract] [Full Text] [Related]

  • 5. [Inhaled antibiotics in the treatment of noncystic fibrosis bronchiectasis].
    Martínez García MÁ, Soler Cataluña JJ, Serra PC.
    Arch Bronconeumol; 2011 Jun; 47 Suppl 6():19-23. PubMed ID: 21703475
    [Abstract] [Full Text] [Related]

  • 6. The Rationale and Evidence for Use of Inhaled Antibiotics to Control Pseudomonas aeruginosa Infection in Non-cystic Fibrosis Bronchiectasis.
    Dhand R.
    J Aerosol Med Pulm Drug Deliv; 2018 Jun; 31(3):121-138. PubMed ID: 29077527
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Aerosolized antibiotics for non-cystic fibrosis bronchiectasis.
    Rubin BK.
    J Aerosol Med Pulm Drug Deliv; 2008 Mar; 21(1):71-6. PubMed ID: 18518833
    [Abstract] [Full Text] [Related]

  • 10. Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis.
    Bilton D, Henig N, Morrissey B, Gotfried M.
    Chest; 2006 Nov; 130(5):1503-10. PubMed ID: 17099030
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Challenges in managing Pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis.
    Wilson R, Aksamit T, Aliberti S, De Soyza A, Elborn JS, Goeminne P, Hill AT, Menendez R, Polverino E.
    Respir Med; 2016 Aug; 117():179-89. PubMed ID: 27492530
    [Abstract] [Full Text] [Related]

  • 13. Evidence for the efficacy of aztreonam for inhalation solution in the management of Pseudomonas aeruginosa in patients with cystic fibrosis.
    Hansen C, Skov M.
    Ther Adv Respir Dis; 2015 Feb; 9(1):16-21. PubMed ID: 25471692
    [Abstract] [Full Text] [Related]

  • 14. Managing Pseudomonas aeruginosa respiratory infections in cystic fibrosis.
    Langan KM, Kotsimbos T, Peleg AY.
    Curr Opin Infect Dis; 2015 Dec; 28(6):547-56. PubMed ID: 26524327
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Novel inhaled combined antibiotic formulations in the treatment of Pseudomonas aeruginosa airways infections in cystic fibrosis.
    Antoniu S.
    Expert Rev Anti Infect Ther; 2015 Jul; 13(7):897-905. PubMed ID: 25921312
    [Abstract] [Full Text] [Related]

  • 20. Inhaled antibiotics: A promising drug delivery strategies for efficient treatment of lower respiratory tract infections (LRTIs) associated with antibiotic resistant biofilm-dwelling and intracellular bacterial pathogens.
    Islam N, Reid D.
    Respir Med; 2024 Jun; 227():107661. PubMed ID: 38729529
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.